Cargando…

Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis

AIM: This study was designed to investigate the relationships of serum matrix metalloproteinase 9 (MMP-9) level and treatment response in esophageal squamous cell carcinoma (ESCC) patients treated with chemotherapy or concurrent radiotherapy. METHODS: Blood samples from ESCC patients after chemother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Ziqi, Zhao, Hongying, Zhou, Wuyuan, Ye, Tao, Geng, Chong, Li, Xiaofeng, Yuan, Lei, Du, Mingyu, Xu, Heng, Wang, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751709/ https://www.ncbi.nlm.nih.gov/pubmed/33364781 http://dx.doi.org/10.2147/OTT.S280791

Ejemplares similares

Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma
por: Mukherjee, Sumana, et al.
Publicado: (2010)

Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients
por: Zhao, Lina, et al.
Publicado: (2017)

Matrix Metalloproteinase 1, 3, and 9 Polymorphisms and Esophageal Squamous Cell Carcinoma Risk
por: Guan, Xuan, et al.
Publicado: (2014)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

Postoperative Concurrent Chemoradiotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
por: Li, Hui, et al.
Publicado: (2022)

Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma
por: Li, Yi, et al.
Publicado: (2013)

Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma
por: Chen, Yu-Kuei, et al.
Publicado: (2016)

Epigenetic regulation of matrix metalloproteinases in inflammatory diseases: a narrative review
por: He, Jie, et al.
Publicado: (2020)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II–III Esophageal Squamous Cell Carcinoma
por: Zhu, Huiping, et al.
Publicado: (2022)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Zhang, Peng, et al.
Publicado: (2016)

Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma
por: Lin, Wei-Cheng, et al.
Publicado: (2019)

Association of Matrix Metalloproteinase-7 (-181A>G) Polymorphism with Risk of Esophageal Squamous Cell Carcinoma in Kashmir Valley
por: Malik, Manzoor A., et al.
Publicado: (2011)

Matrix metalloproteinase‐14 (MMP‐14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation
por: Chen, Nanzheng, et al.
Publicado: (2020)

Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma
por: Yu, Xiang-Yang, et al.
Publicado: (2022)

Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma
por: Eltayeb, Majdolin Mohammed, et al.
Publicado: (2022)

A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly
por: Guo, SuPing, et al.
Publicado: (2021)

Expression of matrix metalloproteinase-12 in aortic dissection
por: Song, Yi, et al.
Publicado: (2013)

Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma
por: Zhu, Han-Ting, et al.
Publicado: (2017)

A phase II study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer
por: Ji, Yongling, et al.
Publicado: (2017)

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Yongxiang, et al.
Publicado: (2020)

Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
por: Li, Hui, et al.
Publicado: (2022)

Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma
por: Mishev, Georgi, et al.
Publicado: (2014)

Expression of Matrix Metalloproteinase-21 in Oral Squamous Cell Carcinoma
por: Baskaran, Adhithya, et al.
Publicado: (2023)

Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis
por: Song, Guo-Min, et al.
Publicado: (2017)

The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process
por: Barillari, Giovanni
Publicado: (2020)

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study
por: Xu, Yaping, et al.
Publicado: (2015)

Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy
por: Kuo, Yao‐Hung, et al.
Publicado: (2019)

Phase II Trial of Intensity-Modulated Radiotherapy Concurrent With Chemotherapy for Postoperative Node-Positive Esophageal Squamous Cell Carcinoma
por: Tao, Hua, et al.
Publicado: (2017)

CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas
por: Lüke, Julia, et al.
Publicado: (2016)

Icotinib With Concurrent Radiotherapy vs Radiotherapy Alone in Older Adults With Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Randomized Clinical Trial
por: Luo, Honglei, et al.
Publicado: (2020)

Fluctuating Roles of Matrix Metalloproteinase-9 in Oral Squamous Cell Carcinoma
por: Vilen, Suvi-Tuuli, et al.
Publicado: (2013)

Serum VEGF levels as a predictor of recurrence in patients with advanced‑stage esophageal squamous cell carcinoma following curative esophagectomy followed by chemotherapy or concurrent radiotherapy
por: Xu, Heng, et al.
Publicado: (2023)

Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma
por: Bai, Xue, et al.
Publicado: (2017)

Anti-Metastatic and Anti-Inflammatory Effects of Matrix Metalloproteinase Inhibition by Ginsenosides
por: Lee, Sang Yeol
Publicado: (2021)

Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern
por: Bao, Yong, et al.
Publicado: (2013)

Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

Impact of Platelets to Lymphocytes Ratio and Lymphocytes during Radical Concurrent Radiotherapy and Chemotherapy on Patients with Nonmetastatic Esophageal Squamous Cell Carcinoma
por: Zhang, Yaotian, et al.
Publicado: (2022)

Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma
por: Grzelczyk, Weronika Lucas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sb8o8qb3nfr64rosl4a1lp0jg7